Suppr超能文献

凝血检测样本采集的质量标准。

Quality standards for sample collection in coagulation testing.

机构信息

Department of Pathology and Laboratory Medicine, Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy.

出版信息

Semin Thromb Hemost. 2012 Sep;38(6):565-75. doi: 10.1055/s-0032-1315961. Epub 2012 Jun 5.

Abstract

Preanalytical activities, especially those directly connected with blood sample collection and handling, are the most vulnerable steps throughout the testing process. The receipt of unsuitable samples is commonplace in laboratory practice and represents a serious problem, given the reliability of test results can be adversely compromised following analysis of these specimens. The basic criteria for an appropriate and safe venipuncture are nearly identical to those used for collecting blood for clinical chemistry and immunochemistry testing, and entail proper patient identification, use of the correct technique, as well as appropriate devices and needles. There are, however, some peculiar aspects, which are deemed to be particularly critical when collecting quality specimens for clot-based tests, and these require clearer recognition. These include prevention of prolonged venous stasis, collection of nonhemolyzed specimens, order of draw, and appropriate filling and mixing of the primary collection tubes. All of these important preanalytical issues are discussed in this article, and evidence-based suggestions as well as recommendations on how to obtain a high-quality sample for coagulation testing are also illustrated. We have also performed an investigation aimed to identify variation of test results due to underfilling of primary blood tubes, and have identified a clinically significant bias in test results when tubes are drawn at less than 89% of total fill for activated partial thromboplastin time, less than 78% for fibrinogen, and less than 67% for coagulation factor VIII, whereas prothrombin time and activated protein C resistance remain relatively reliable even in tubes drawn at 67% of the nominal volume.

摘要

在整个检测过程中,前处理活动,特别是与血液样本采集和处理直接相关的活动,是最脆弱的步骤。在实验室实践中,收到不合适的样本是很常见的,这是一个严重的问题,因为这些标本的分析会对检测结果的可靠性产生不利影响。适当且安全的静脉穿刺的基本标准与用于临床化学和免疫化学检测的标准几乎相同,需要正确识别患者、使用正确的技术以及适当的设备和针头。然而,在收集基于凝结块的测试的高质量样本时,有一些特殊的方面被认为是特别关键的,这些方面需要更清晰的认识。这些方面包括预防静脉淤滞时间延长、采集未溶血的样本、采血顺序以及适当的初级采集管的填充和混合。本文讨论了所有这些重要的前处理问题,并提出了基于证据的建议以及如何获得高质量凝血测试样本的建议。我们还进行了一项调查,旨在确定由于初级血液管未充分填充而导致的测试结果的变化,并发现当激活部分凝血活酶时间的管填充不足 89%、纤维蛋白原的管填充不足 78%和凝血因子 VIII 的管填充不足 67%时,测试结果存在临床显著偏差,而当管填充不足 67%时,凝血酶原时间和活化蛋白 C 抵抗仍然相对可靠。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验